Cargando…
Clinical Utility of Novel Biomarkers in the Prediction of Coronary Heart Disease
Coronary heart disease (CHD) is a significant cause of morbidity and mortality worldwide. Many risk prediction models have been developed in an effort to assist clinicians in risk assessment and the prevention of CHD. However, it is unclear whether the existing CHD prediction tools can improve clini...
Autor principal: | Kim, Hyeon Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341417/ https://www.ncbi.nlm.nih.gov/pubmed/22563333 http://dx.doi.org/10.4070/kcj.2012.42.4.223 |
Ejemplares similares
-
Clinical utility of platinum chromium bare-metal stents in coronary heart disease
por: Jorge, Claudia, et al.
Publicado: (2015) -
Conventional Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease
por: Mănescu, Ion-Bogdan, et al.
Publicado: (2022) -
Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease
por: Pál, Krisztina, et al.
Publicado: (2023) -
Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
por: Zhou, Bo-Da, et al.
Publicado: (2015) -
Bioinformatics Analysis to Find Novel Biomarkers for Coronary Heart Disease
por: Gholipour, Akram, et al.
Publicado: (2022)